Tislelizumab (Bgb-A317) For Relapsed/Refractory Classical Hodgkin Lymphoma: Long-Term Follow-Up Efficacy And Safety Results From A Phase 2 Study
Tislelizumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Tislelizumab (Bgb-A317) For Relapsed/Refractory Classical Hodgkin Lymphoma: Long-Term Follow-Up Efficacy And Safety Results From A Phase 2 Study ### Output: Tislelizumab